-
Something wrong with this record ?
Changes of selected hematologic parameters during long-term immunoadsorption therapy
Pták J.
Language English Country Great Britain
- MeSH
- Time Factors MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Myasthenia Gravis complications blood therapy MeSH
- Leukocyte Count MeSH
- Aged MeSH
- Blood Component Removal adverse effects MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
Changes of selected hematologic parameters were studied in six patients treated with immunoadsorption for myasthenia gravis. The mean duration of therapy was 18.6months; 245 procedures were performed in total. Before and after each procedure the full blood count was examined. A decrease was noted in the hemoglobin concentration (median -7.27%) and in platelet count (median -5.63%) after each procedure. On the other hand, an increase in leukocyte count was noticed after each procedure (median 6.63%). However, in three patients, it was observed that with increasing numbers of procedures, the leukocyte count rises were lower during long-term treatment. We suppose that the decrease in hemoglobin concentration was induced both by the large volume of blood samples collected for laboratory testing and by the residual volume of blood which remains in the tubing. From the continuous decrease in leukocyte count after long-term treatment with immunoadsorption in our three patients, it may be concluded, that some type of immunomodulatory effect (immunosuppression) is involved.
References provided by Crossref.org
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07520372
- 003
- CZ-PrNML
- 005
- 20111210131110.0
- 008
- 090331s2005 xxk e eng||
- 009
- AR
- 024 __
- $a 10.1016/j.transci.2005.05.004 $2 doi
- 035 __
- $a (PubMed)16203175
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Pták, Jan, $d 1950- $7 xx0034439
- 245 10
- $a Changes of selected hematologic parameters during long-term immunoadsorption therapy / $c Pták J.
- 314 __
- $a Blood Center of University Hospital, 17 listopadu 833, 708 52 Ostrava-Poruba, Czech Republic. jan.ptak@fnspo.cz
- 520 9_
- $a Changes of selected hematologic parameters were studied in six patients treated with immunoadsorption for myasthenia gravis. The mean duration of therapy was 18.6months; 245 procedures were performed in total. Before and after each procedure the full blood count was examined. A decrease was noted in the hemoglobin concentration (median -7.27%) and in platelet count (median -5.63%) after each procedure. On the other hand, an increase in leukocyte count was noticed after each procedure (median 6.63%). However, in three patients, it was observed that with increasing numbers of procedures, the leukocyte count rises were lower during long-term treatment. We suppose that the decrease in hemoglobin concentration was induced both by the large volume of blood samples collected for laboratory testing and by the residual volume of blood which remains in the tubing. From the continuous decrease in leukocyte count after long-term treatment with immunoadsorption in our three patients, it may be concluded, that some type of immunomodulatory effect (immunosuppression) is involved.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a separace krevních složek $x škodlivé účinky $7 D001781
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a počet leukocytů $7 D007958
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a myasthenia gravis $x komplikace $x krev $x terapie $7 D009157
- 650 _2
- $a časové faktory $7 D013997
- 773 0_
- $w MED00008583 $t Transfusion and apheresis science $g Roč. 33, č. 3 (2005), s. 299-304 $x 1473-0502
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090310084605 $b ABA008
- 991 __
- $a 20090331171418 $b ABA008
- 999 __
- $a ok $b bmc $g 638175 $s 490974
- BAS __
- $a 3
- BMC __
- $a 2005 $b 33 $c 3 $d 299-304 $i 1473-0502 $m Transfusion and apheresis science $x MED00008583
- LZP __
- $a 2009-B2/ipme